Your browser doesn't support javascript.
loading
Response: Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study (Diabetes Metab J 2019;43:640–8)
Article in En | WPRIM | ID: wpr-785695
Responsible library: WPRO
ABSTRACT
No abstract available.
Subject(s)
Full text: 1 Index: WPRIM Main subject: Cohort Studies / Diabetic Retinopathy / Hypoglycemic Agents / Metformin Type of study: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Language: En Journal: Diabetes & Metabolism Journal Year: 2019 Type: Article
Full text: 1 Index: WPRIM Main subject: Cohort Studies / Diabetic Retinopathy / Hypoglycemic Agents / Metformin Type of study: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Language: En Journal: Diabetes & Metabolism Journal Year: 2019 Type: Article